Dr. Martens plc Financials

Market Capitalization £741.7 Million as of July 1, 2025

Valuations Metrics as of May. 5, 2024

Trailing PE	809.00
Forward PE	0.17
Price to Sales TTM	£0.80
Price to Book MRQ	£219.84
Enterprise to Revenue	1.30
Enterprise to EBITDA	7.00

Financial Reports as of Sep. 30, 2023

Financials

Fiscal Year Ends	2023-03-31
Most Recent Quarter	2023-09-30
Profit Margin	10.56%
Operating Margin	10.18%
Return on Assets TTM	10.31%
Return on Equity TTM	29.07%

Income Statement

Revenue TTM	£977,500,032
Revenue per Share TTM	£0.98
Quarterly Revenue Growth	-5.40%
Gross Profit TTM	£618,100,000
EBITDA	£238,900,000
Net Income to Common TTM	£103,200,000
Diluted EPS TTM	£0.10
Quarterly Earnings Growth YoY	-57.50%

Balance Sheet

Total Cash MRQ	£45,700,000
Total Cash per Share MRQ	£0.05
Total Debt MRQ	£
Total Debt to Equity MRQ	143.48
Current Ratio MRQ	2.44
Book Value per Share MRQ	£0.37

Cash Flow

Operating Cash Flow TTM	£76,500,000
Levered Free Cash Flow TTM	£-475,000

DOCS Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	961,936,000
Float Shares	528,745,433
Avg 10 Volume	3,969,321
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	2.77%
% Held by Institutions	73.30%

Stock Price Summary

Beta	-0.03
Fifty Two Week Low	£62.00
Fifty Two Week High	£174.70
Fifty Two Week Change	-103.46%
Day 50 MA	£86.71
Day 200 MA	£108.81

Dividends and Splits

Forward Annual Dividend Rate	£6.24
Forward Annual Dividend Yield	7.71%
Trailing Annual Dividend Rate	£5.84
Trailing Annual Dividend Yield	7.22%
Payout Ratio	56.70%
Dividend Date
Ex Dividend Date	2024-01-04
Last Split Factor
Last Split Date